ConductScience.org, home

Paper2665645

Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis.

Fantin B and 6 others. Antimicrob Agents Chemother, 1989. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis. Papers, record 2665645. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2665645

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1989
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
1.99
iCite
Revised in PubMed
2021-05-26
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fantin BB
2Pangon BB
3Potel GG
4Vallois JMJ M
5Caron FF
6Bure AA
7Carbon CC

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CeftriaxoneMajor topic
Endocarditis, BacterialMajor topic
Escherichia coli InfectionsMajor topic
NetilmicinMajor topic
Animals
Drug Combinations
Female
Half-Life
Humans
Male
Rabbits

Source PubMed

Download CSV of topics

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16093513Pharmacokinetic profile of ceftriaxone in man.Am J Med1984https://conductscience.org/library/papers/6093513PubMed
24091526Comparison of penicillin and vancomycin, individually and in combination with gentamicin and amikacin, in the treatment of experimental endocarditis induced by nutritionally variant streptococci.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/4091526PubMed
33516963Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditis.J Antimicrob Chemother1986https://conductscience.org/library/papers/3516963PubMed
43540140Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration.J Infect Dis1987https://conductscience.org/library/papers/3540140PubMed
53300530Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3300530PubMed
66795989Minimal concentrations of aminoglycoside that can synergize with penicillin in enterococcal endocarditis.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6795989PubMed
73324957Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3324957PubMed
83134490The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess.J Infect Dis1988https://conductscience.org/library/papers/3134490PubMed
93392422Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia.J Infect Dis1988https://conductscience.org/library/papers/3392422PubMed
102971498Tolerance of once-daily dosing of netilmicin and teicoplanin, alone or in combination, in healthy volunteers.Clin Pharmacol Ther1988https://conductscience.org/library/papers/2971498PubMed
11512417The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure.J Infect Dis1979https://conductscience.org/library/papers/512417PubMed
123121761In vivo postantibiotic effect in a thigh infection in neutropenic mice.J Infect Dis1988https://conductscience.org/library/papers/3121761PubMed

Download CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
25210404Netilmicin-induced carpopedal spasm.J Pharmacol Pharmacother2014https://conductscience.org/library/papers/25210404PubMed
24587365Beneficial antimicrobial effect of the addition of an aminoglycoside to a β-lactam antibiotic in an E. coli porcine intensive care severe sepsis model.PLoS One2014https://conductscience.org/library/papers/24587365PubMed
23807657Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.Clin Pharmacokinet2013https://conductscience.org/library/papers/23807657PubMed
10223909Effectiveness and toxicity of gentamicin in an experimental model of pyelonephritis: effect of the time of administration.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/10223909PubMed
8878597Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8878597PubMed
8851618Temporal variation in nephrotoxicity of low doses of isepamicin in rats.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8851618PubMed
8452350Synergistic activity of ceftriaxone combined with netilmicin administered once daily for treatment of experimental streptococcal endocarditis.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8452350PubMed
8239615Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8239615PubMed
8031041Ceftriaxone protects against tobramycin nephrotoxicity.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8031041PubMed
2188586Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2188586PubMed
2128443Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2128443PubMed
2014965Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/2014965PubMed
1759831Single daily dosing of antibiotics: importance of in vitro killing rate, serum half-life, and protein binding.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1759831PubMed
1510412In vivo antibiotic synergism: contribution of animal models.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1510412PubMed
1444286Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1444286PubMed
1329634Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1329634PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2665645

GET https://conductscience.org/api/papers/v1/2665645/authors